Compare JUBILANT LIFE SCIENCES with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES ALEMBIC PHARMA JUBILANT LIFE SCIENCES/
ALEMBIC PHARMA
 
P/E (TTM) x 13.7 15.8 86.8% View Chart
P/BV x 1.7 3.9 43.6% View Chart
Dividend Yield % 0.9 1.0 89.6%  

Financials

 JUBILANT LIFE SCIENCES   ALEMBIC PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
ALEMBIC PHARMA
Mar-19
JUBILANT LIFE SCIENCES/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs898664 135.2%   
Low Rs618412 149.7%   
Sales per share (Unadj.) Rs572.0208.7 274.1%  
Earnings per share (Unadj.) Rs36.231.0 116.9%  
Cash flow per share (Unadj.) Rs59.537.1 160.4%  
Dividends per share (Unadj.) Rs4.505.50 81.8%  
Dividend yield (eoy) %0.61.0 58.1%  
Book value per share (Unadj.) Rs301.9144.2 209.3%  
Shares outstanding (eoy) m159.28188.52 84.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.32.6 51.4%   
Avg P/E ratio x20.917.4 120.5%  
P/CF ratio (eoy) x12.714.5 87.8%  
Price / Book Value ratio x2.53.7 67.3%  
Dividend payout %12.417.7 70.0%   
Avg Mkt Cap Rs m120,694101,461 119.0%   
No. of employees `0002.4NA-   
Total wages/salary Rs m19,2607,467 257.9%   
Avg. sales/employee Rs Th38,120.6NM-  
Avg. wages/employee Rs Th8,058.4NM-  
Avg. net profit/employee Rs Th2,414.3NM-  
INCOME DATA
Net Sales Rs m91,10839,347 231.6%  
Other income Rs m35794 381.0%   
Total revenues Rs m91,46639,441 231.9%   
Gross profit Rs m17,3908,736 199.1%  
Depreciation Rs m3,7091,152 321.9%   
Interest Rs m2,198184 1,194.0%   
Profit before tax Rs m11,8407,493 158.0%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m-2,8020-   
Tax Rs m3,2681,568 208.5%   
Profit after tax Rs m5,7705,844 98.7%  
Gross profit margin %19.122.2 86.0%  
Effective tax rate %27.620.9 131.9%   
Net profit margin %6.314.9 42.6%  
BALANCE SHEET DATA
Current assets Rs m45,84819,577 234.2%   
Current liabilities Rs m20,89714,896 140.3%   
Net working cap to sales %27.411.9 230.2%  
Current ratio x2.21.3 166.9%  
Inventory Days Days5790 63.3%  
Debtors Days Days5145 112.3%  
Net fixed assets Rs m65,49827,097 241.7%   
Share capital Rs m159377 42.3%   
"Free" reserves Rs m47,93026,811 178.8%   
Net worth Rs m48,08927,188 176.9%   
Long term debt Rs m42,4294,993 849.8%   
Total assets Rs m114,68547,778 240.0%  
Interest coverage x6.441.7 15.3%   
Debt to equity ratio x0.90.2 480.4%  
Sales to assets ratio x0.80.8 96.5%   
Return on assets %6.912.6 55.1%  
Return on equity %12.021.5 55.8%  
Return on capital %12.423.6 52.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,42219,453 63.9%   
Fx outflow Rs m17,2276,065 284.0%   
Net fx Rs m-4,80513,388 -35.9%   
CASH FLOW
From Operations Rs m11,2158,120 138.1%  
From Investments Rs m-10,118-7,556 133.9%  
From Financial Activity Rs m6,574590 1,113.5%  
Net Cashflow Rs m7,6121,153 660.0%  

Share Holding

Indian Promoters % 45.6 74.1 61.5%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 2.9 300.0%  
FIIs % 21.2 9.1 233.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 13.9 151.8%  
Shareholders   23,815 49,328 48.3%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   SANOFI INDIA  ABBOTT INDIA  STRIDES PHARMA SCIENCE  CIPLA  GSK PHARMA  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 229 Points Lower; Banking and Metal Stocks Witness Selling(Closing)

Indian share markets fell sharply during closing hours today amid weak global cues and disappointing domestic factory output data.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Nov 13, 2019 03:37 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS